PL336626A1 - Methods of preventing and treating traumatic loss of metabolic equlibrium among human beings and animals - Google Patents

Methods of preventing and treating traumatic loss of metabolic equlibrium among human beings and animals

Info

Publication number
PL336626A1
PL336626A1 PL98336626A PL33662698A PL336626A1 PL 336626 A1 PL336626 A1 PL 336626A1 PL 98336626 A PL98336626 A PL 98336626A PL 33662698 A PL33662698 A PL 33662698A PL 336626 A1 PL336626 A1 PL 336626A1
Authority
PL
Poland
Prior art keywords
equlibrium
metabolic
animals
preventing
methods
Prior art date
Application number
PL98336626A
Other languages
English (en)
Inventor
Marian L Kruzel
Gilbert A Castro
Original Assignee
Regents Board Of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regents Board Of filed Critical Regents Board Of
Publication of PL336626A1 publication Critical patent/PL336626A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL98336626A 1997-05-03 1998-04-30 Methods of preventing and treating traumatic loss of metabolic equlibrium among human beings and animals PL336626A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4552197P 1997-05-03 1997-05-03
PCT/US1998/009053 WO1998050076A1 (fr) 1997-05-03 1998-04-30 Methodes de prevention et de traitement du desequilibre metabolique induit par insulte chez les humains et des animaux

Publications (1)

Publication Number Publication Date
PL336626A1 true PL336626A1 (en) 2000-07-03

Family

ID=21938377

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98336626A PL336626A1 (en) 1997-05-03 1998-04-30 Methods of preventing and treating traumatic loss of metabolic equlibrium among human beings and animals

Country Status (5)

Country Link
EP (1) EP0980261A4 (fr)
AU (1) AU7368198A (fr)
CA (1) CA2288982A1 (fr)
PL (1) PL336626A1 (fr)
WO (1) WO1998050076A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030203839A1 (en) * 1999-10-29 2003-10-30 Kruzel Marian L. Immune enhancing composition containing lactoferrin
US20060204549A1 (en) * 2003-01-07 2006-09-14 N.V. Nutricia Method of improving nutrient utilisation by a mammal and a composition for use therein
ITMI20052351A1 (it) 2005-12-09 2007-06-10 Microbo Srl Nuovo uso farmaceutico delle transferrine e composizioni farmaceutiche derivate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
DE4008033A1 (de) * 1990-03-14 1991-09-19 Nitsche Dietrich Verwendung von lactoferrin zur bekaempfung der toxischen wirkung des endotoxins
CA2090658A1 (fr) * 1992-03-02 1993-09-03 Kunio Ando Composition pharmaceutique utilisable pour le traitement ou la prevention de maladies infectieuses opportunistes compliquees d'une infection a lentivirus
US5792751A (en) * 1992-04-13 1998-08-11 Baylor College Of Medicine Tranformation of cells associated with fluid spaces
JPH08217693A (ja) * 1995-02-17 1996-08-27 Yoshihisa Naito 新規医薬組成物
IT1278137B1 (it) * 1995-07-12 1997-11-17 Piera Valenti Utilizzo della lattoferrina per la terapia topica delle infezioni acute o recidivanti causate da "streptococcus pyogenes" o da altri
WO1998006425A1 (fr) * 1996-08-12 1998-02-19 A+ Science Invest Ab Traitement et prevention d'infections, d'inflammations et/ou de tumeurs a l'aide de lactoferrine et/ou de lactoferricine
US6333311B1 (en) * 1997-02-03 2001-12-25 Pharming Useful properties of human lactoferrin and variants thereof
WO1998044940A1 (fr) * 1997-04-10 1998-10-15 Agennix, Inc. Utilisation de la lactoferrine dans le traitement des troubles induits par allergenes

Also Published As

Publication number Publication date
EP0980261A4 (fr) 2003-04-23
CA2288982A1 (fr) 1998-11-12
EP0980261A1 (fr) 2000-02-23
AU7368198A (en) 1998-11-27
WO1998050076A1 (fr) 1998-11-12

Similar Documents

Publication Publication Date Title
GB9500247D0 (en) Treatment of poultry
PL324010A1 (en) Methods of preventing and treating allergic states
EP0863747A4 (fr) Stimulatiion des follicules pileux
IL118247A0 (en) Use of R-enantiomer of N-propargyl-1-aminoindan and its salts
GB2334444B (en) Hair treatment composition and method of manufacturing the composition
AUPN033894A0 (en) Prevention of adverse behaviour in humans and animals
PL312718A1 (en) Competitors and opponents of human interleukine-10
HUP9901320A3 (en) Synergistic herbicidal composition and method of use thereof
GR3033229T3 (en) Methods of attracting and combatting insects
PL336760A1 (en) Treatment of skin diseases
HUP9800146A3 (en) Thalidomide-derivatives and use of them
PL336626A1 (en) Methods of preventing and treating traumatic loss of metabolic equlibrium among human beings and animals
DE59306085D1 (de) Haar- und körperbehandlungsmittel
EP1009433A4 (fr) Composition therapeutique et procede de traitement
PL322002A1 (en) Variants of human dnase i
GB2321644B (en) Cosmetic composition for the treatment of the hair and/or the body
GB9711848D0 (en) Treatment and prophylaxis of infraction
IL119282A0 (en) Treatment of fowl
EP1015559A4 (fr) Serfine-1 (rasp-1) associee a la regeneration humaine et methodes d'utilisation
GB9516572D0 (en) Prevention and/or treatment of disease
AUPN201895A0 (en) Treatment of humans and animals
GB2324962B (en) Treatment of allergic conditions
PL342649A1 (en) Prevention of amyloidogenous diseases and treatment of them
AUPM647994A0 (en) Treatment of animal hair
GB9323066D0 (en) Treatment of small animals

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)